Steroid hormone receptors and drug discovery: Therapeutic opportunities and assay designs

被引:21
作者
Bai, C [1 ]
Schmidt, A [1 ]
Freedman, LP [1 ]
机构
[1] Merck Res Labs, Dept Mol Endocrinol, West Point, PA 19486 USA
关键词
D O I
10.1089/154065803772613471
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Steroid receptors belong to the nuclear hormone receptor superfamily, which represents one of the important families of drug targets in the pharmaceutical industry. These receptors are generally expressed in a broad range of tissues and play roles in multiple physiological pathways. They represent one of the most complex target classes for drug research as the typical pharmacologically selective, potent, and pure agonist or antagonist may not be sufficient for the development of an optimal compound for therapeutic use. In many cases, the professed compound that is a selective modulator of a steroid hormone receptor that functions as an agonist in one tissue and as an antagonist in another can offer a better therapeutic advantage. In this review, we will selectively summarize members of the steroid hormone receptor subfamily, their therapeutic opportunities, and a glimpse of the methods that can be utilized in the development of drugs that target these receptors.
引用
收藏
页码:843 / 852
页数:10
相关论文
共 68 条
  • [41] Microarray analysis of genes controlled by progesterone in human endometrial stromal cells in vitro
    Okada, H
    Nakajima, T
    Yoshimura, T
    Yasuda, K
    Kanzaki, H
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2003, 17 (04) : 271 - 280
  • [42] Receptor modulators in reproductive health role
    Olive, DL
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2002, 57 (11) : S55 - S63
  • [43] Differential ligand activation of estrogen receptors ER alpha and ER beta at AP1 sites
    Paech, K
    Webb, P
    Kuiper, GGJM
    Nilsson, S
    Gustafsson, JA
    Kushner, PJ
    Scanlan, TS
    [J]. SCIENCE, 1997, 277 (5331) : 1508 - 1510
  • [44] Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells
    Rahman, MM
    Miyamoto, H
    Lardy, H
    Chang, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (09) : 5124 - 5129
  • [45] The nuclear receptor superfamily
    Robinson-Rechavi, M
    Garcia, HE
    Laudet, V
    [J]. JOURNAL OF CELL SCIENCE, 2003, 116 (04) : 585 - 586
  • [46] Rationale for the use of aldosterone antagonists in congestive heart failure
    Rocha, R
    Williams, GH
    [J]. DRUGS, 2002, 62 (05) : 723 - 731
  • [47] Dissecting mineralocorticoid receptor structure and function
    Rogerson, FM
    Brennan, FE
    Fuller, PJ
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 85 (2-5) : 389 - 396
  • [48] Coregulator codes of transcriptional regulation by nuclear receptors
    Rosenfeld, MG
    Glass, CK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (40) : 36865 - 36868
  • [49] Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
    Rossouw, JE
    Anderson, GL
    Prentice, RL
    LaCroix, AZ
    Kooperberg, C
    Stefanick, ML
    Jackson, RD
    Beresford, SAA
    Howard, BV
    Johnson, KC
    Kotchen, JM
    Ockene, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03): : 321 - 333
  • [50] PHARMACOLOGICAL AND FUNCTIONAL-CHARACTERIZATION OF HUMAN MINERALOCORTICOID AND GLUCOCORTICOID RECEPTOR LIGANDS
    RUPPRECHT, R
    REUL, JMHM
    VANSTEENSEL, B
    SPENGLER, D
    SODER, M
    BERNING, B
    HOLSBOER, F
    DAMM, K
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 247 (02): : 145 - 154